XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2018
Mar. 31, 2017
Operating expenses        
General and administrative $ 1,489,450 $ 1,116,014 $ 2,887,253 $ 2,242,198
Research and development 3,245,023 2,492,933 5,939,335 4,535,423
Total operating expenses (4,734,473) (3,608,947) (8,826,588) (6,777,621)
Other income (expenses)        
Grant income 16,684 51,970
Research and development incentive income 2,022,902 2,022,902
Interest income, net 28,647 18,147 59,023 21,802
Foreign exchange gain (loss) (18,337) 11,722 (6,358) 25,804
Total other income 10,310 2,069,455 52,665 2,122,478
Net loss before provision for income taxes (4,724,163) (1,539,492) (8,773,923) (4,655,143)
Income tax expense (27,861) (9,595) (37,266) (40,603)
Net loss and comprehensive loss $ (4,752,024) $ (1,549,087) $ (8,811,189) $ (4,695,746)
Loss per share        
Basic and diluted (in dollars per share) $ (0.11) $ (0.04) $ (0.2) $ (0.12)
Weighted average number of shares outstanding        
Basic and diluted (in shares) 44,545,523 41,159,707 44,210,591 39,761,612